184 related articles for article (PubMed ID: 7485076)
1. Reticulated platelets in uremic patients: effect of hemodialysis and continuous ambulatory peritoneal dialysis.
Tàssies D; Reverter JC; Cases A; Escolar G; Villamor N; López-Pedret J; Castillo R; Ordinas A
Am J Hematol; 1995 Nov; 50(3):161-6. PubMed ID: 7485076
[TBL] [Abstract][Full Text] [Related]
2. Increased reticulated platelets in dialysis patients.
Himmelfarb J; Holbrook D; McMonagle E; Ault K
Kidney Int; 1997 Mar; 51(3):834-9. PubMed ID: 9067918
[TBL] [Abstract][Full Text] [Related]
3. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling.
Díaz-Ricart M; Estebanell E; Cases A; Calls J; López-Pedret J; Carretero M; Castillo R; Ordinas A; Escolar G
Kidney Int; 2000 May; 57(5):1905-14. PubMed ID: 10792609
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: association with early improvement in platelet function.
Tàssies D; Reverter JC; Cases A; Calls J; Escolar G; Ordinas A
Am J Hematol; 1998 Oct; 59(2):105-9. PubMed ID: 9766793
[TBL] [Abstract][Full Text] [Related]
5. Plasma and platelet von Willebrand factor defects in uremia.
Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
[TBL] [Abstract][Full Text] [Related]
6. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors.
Sreedhara R; Itagaki I; Hakim RM
Am J Kidney Dis; 1996 Mar; 27(3):355-64. PubMed ID: 8604704
[TBL] [Abstract][Full Text] [Related]
7. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
[TBL] [Abstract][Full Text] [Related]
8. Platelet aggregation and prostaglandin metabolism in uremic patients.
Pietrzak I; Komarnicki M; Zaremba-Drobnik D
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S111-4. PubMed ID: 11576934
[TBL] [Abstract][Full Text] [Related]
9. Enhanced platelet apoptosis in chronic uremic patients.
Li M; Wang Z; Ma T; Lu G; Yan R; Zhao L; Deng K; Dai K
Ren Fail; 2014 Jul; 36(6):847-53. PubMed ID: 24655051
[TBL] [Abstract][Full Text] [Related]
10. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
Salvati F; Liani M
Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma glycocalicin levels and decreased ristocetin-induced platelet agglutination in hemodialysis patients.
Himmelfarb J; Nelson S; McMonagle E; Holbrook D; Benoit SE; Michelson AD; Ault K
Am J Kidney Dis; 1998 Jul; 32(1):132-8. PubMed ID: 9669434
[TBL] [Abstract][Full Text] [Related]
12. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
13. Reduction of platelet glycoprotein Ib in uraemia.
Sloand EM; Sloand JA; Prodouz K; Klein HG; Yu MW; Harvath L; Fricke W
Br J Haematol; 1991 Mar; 77(3):375-81. PubMed ID: 2012763
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
16. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
Elshamaa MF; Elghoroury EA; Helmy A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
[TBL] [Abstract][Full Text] [Related]
17. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis.
Malyszko J; Malyszko JS; Mysliwiec M
Perit Dial Int; 2001; 21(2):158-65. PubMed ID: 11330560
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
20. Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis.
Jørgensen KA; Ingeberg S
Nephron; 1979; 23(5):233-6. PubMed ID: 481658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
